Identify the actual pill
NovoCare currently publishes self-pay prices for FDA-approved Wegovy tablets. A provider advertising a compounded semaglutide pill is describing another preparation. The two should not share an approval label in a comparison table. Likewise, a monthly subscription to a clinical service is not the same product as a bottle of tablets.
Sources: NovoCare — Wegovy pricing by formulation, Ro — membership and medication prices, Wegovy — prescribing information, FDA — compounding questions and answers
Read the strength-specific table
The current NovoCare page lists $149 for thirty 1.5 mg tablets, $199 for thirty 4 mg tablets and $299 for thirty 9 mg or 25 mg tablets. The standard Wegovy pen has a separate $349 recurring self-pay price, with eligibility-specific introductory fills and a separate HD offering. Those figures are medication prices, not guaranteed totals for every patient’s care.
Sources: NovoCare — Wegovy pricing by formulation, Ro — membership and medication prices, Wegovy — prescribing information, FDA — compounding questions and answers
Add care without changing the medicine price
Ro lists a standard ongoing Body membership of $149 alongside medication pricing. Combining that membership with a $149 Wegovy pill price produces a $298 ongoing subtotal for that listed combination. Obtaining the prescription through another clinician can involve a different charge. A manufacturer medicine-only quote should remain distinguishable from a service package.
Sources: NovoCare — Wegovy pricing by formulation, Ro — membership and medication prices, Wegovy — prescribing information, FDA — compounding questions and answers
Do not turn prices into a dose conversion
The labeled directions and strengths differ by formulation. A price-per-milligram figure cannot establish an equivalent dose, exposure or clinical result between an oral and injectable product. Follow the prescribed formulation and its instructions. This site’s calculators perform financial arithmetic and do not calculate doses or advise switching routes.
Sources: NovoCare — Wegovy pricing by formulation, Ro — membership and medication prices, Wegovy — prescribing information, FDA — compounding questions and answers
Follow the evidence
Sources & price notes
Checked October 8, 2026. Provider pages document advertised terms; they do not independently establish clinical outcomes.
- NovoCare — Wegovy pricing by formulation ↗
Official public information; price and terms checked October 8, 2026.
- Ro — membership and medication prices ↗
Official public information; price and terms checked October 8, 2026.
- Wegovy — prescribing information ↗
Formulation-specific approved uses, contraindications and warnings.
- FDA — compounding questions and answers ↗
Clinical and regulatory context. A compounded preparation is not FDA-approved.